Zusammenfassung
Die erste Kardioversion am Menschen wurde 1947 von Beck, Pritchard und Feil bei anhaltender ventrikulärer Tachykardie angewandt (6). In der Folge wurde die Indikation auch auf die Wiederherstellung des Sinusrhythmus bei Vorhofflimmern ausgeweitet. Problematisch war bei der zunächst üblichen Wechselstrom-Defibrillation (AC = amplitude current) das häufige Auftreten von Kammerflimmern. 1966 zeigte der Vergleich von Nachlas et al. (32) die Überlegenheit des sehr viel kürzeren Gleichstromimpulses (DC = direct current) bei der Kardioversion und Defibrillation. Ein weiterer Sicherheitsfaktor wurde 1962 von Lown et al. mit der Synchronisation des abgegebenen Stromimpulses an der R-Zacke erreicht (29) (Abb. 1). Eine zufällige Kardioversion im Bereich der vulnerablen Phase des Ventrikels konnte so vermieden werden. Insbesondere niedrige Kardioversionsenergien waren ansonsten in der Lage Kammerflimmern auszulösen. Die heutigen Geräte zur Kardioversion (synchronisiert) und Defibrillation (unsynchronisiert) arbeiten alle mit einem Gleichstromimpuls und haben die Möglichkeit der Synchronisation (Abb. 2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abernathy WS, Willis PW (1973) Thromboembolic complications of rheumatic heart disease Cardiovasc. Clin 5: 131
Alam M, Thorstrand C (1992) Left Ventricular Function in Patients with Atrial Fibrillation Before and After Cardioversion. Am J Cardiol 69: 694
Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG (1992) Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation and atrial flutter. J Am Coll Cardiol 19: 851
Babbs CF (1981) Alteration of defibrillation threshold by antiarrhythmic drugs: a theoretical framework. Crit Care Med 9: 362
Babbs CF, Tacker WA, VanVleet JF, Bourland JD, Geddes LA (1980) Therapeutic indices for transchest defibrillator shocks: Effective, damaging, and lethal electrical doses. Am Heart J 99: 734
Beck ES, Pritchard WH, Feil HS (1947) Ventricular fibrillation of long duration abolished by electric shock. JAMA 135: 985
Bjerkelund CJ, Orning OM (1969) The efficacy of anticoagulant therapy in preventing embolism related to D. C. electrical conversion of atrial fibrillation. Am J Cardiol 23: 208
Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in non-rheumatic atrial fibrillation. N Engl J Med 323: 1505
Brodsky MA, Allen BJ, Capparelli EV Luckett CR Morton R, Henry WL (1989) Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol 63: 1065
Chauvin M, Koenig A, Brechenmacher C (1991) Le choc electrique interne dans le traitement de fibrillations auriculaires chroniques résistant à la cardioversion externe. Premiers rèsultats à propos de 21 patients. Ann Cardiol Angéiol 40: 47
Chauvin M, Koenig A. Theolade R, Brechenmacher C (1991) La place du choc électrique interne dans le traitement de la fibrillation auriculaire permanente. Arch Mal Coeur 84: 377
Connolly SJ, Laupacis A, Gent M, Roberts RS. Cairns JA, Joyner C (1991) Canadian Atrial Fibrillation Anticoagulation ( CAFA) Study. J Am Coll Cardiol 18: 349
Dalzell GW, Anderson J, Adgey AAJ (1990) Factors Determining Success and Energy Requirements for Cardioversion of Atrial Fibrillation. Quart J Med 76 /281: 903
Dalzell GW, Anderson J, Adgey AAJ (1990) Factors Determining Success and Energy Requirements for Cardioversion of Atrial Fibrillation. Quart J Med 76 /281: 903
De Silva RA, Lown B (1982) Cardioversion for atrial fibrillation-indications and complications. In: Kulbertus HE, Olsson SB, Schlepper M (eds). Atrial fibrillation. AB Hässle, Mölndal, p 231
Dittrich HC, Erickson JS, Schneiderman T. Blacky R, Savides T, Nicod PH (1989) Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 63: 193
Dunn M, Alexander J, de Silva R, Hildner F (1989) Antithrombotic therapy in atrial fibrillation. Chest 95: 118S
Ewy G, Ulfers L, Hager WD, Rosenfeld AR, Roeske WR, Goldman S (1980) Response of atrial fibrillation to therapy: role of etiology and left atrial diameter. J Electrocardiol 13: 119
Germonpré E, Jordaens LJ, Clement L (1990) lntracardiale shocks voor de conversie van chronisch atrium fibrilleren. Ned Tijdschr Geneeskd 134: 1213
Guarnieri T, Tomaselli G, Griffith LSC, Brinker J (1991) The Interaction of Antiarrhythmic Drugs and the Energy for Cardioversion of Chronic Atrial Fibrillation. PACE 14: 1007
Henry WL, Morganroth J, Pearlman AS et al. (1976) Relation between echocardiographic determined left atrial size and atrial flutter. Circulation 53, 273
Jacobs MB (1992) Anticoagulation before Cardioversion for Atrial Fibrillation. Ann Int Med 116: 698
Jakobsson J, Odmansson I, Nordlander R (1990) Enzyme release after elective cardioversion. Europ Heart J 11: 749
Kerber, RE, Jensen SR, Grayzel J, Kennedy J, Hoyt R (1981) Elective Cardioversion: Influence of Paddle-Electrode Location and Size on Success Rates and Energy Requirements. Engl J Med 305: 658
Kumagai K, Yamanouchi Y, Hiroki T, Arakawa K (1991) Effects of Transcatheter Cardioversion on Chronic Lone Atrial Fibrillation. PACE 14: 1571
Kumagai K, Yamanouchi Y, Tashiro N, Hiroki T, Arakawa K (1990) Low Energy Synchronous Transcatheter Cardioversion of Atrial Flutter/Fibrillation in the Dog. J Am Coll Cardio 116: 497
Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye R L (1987) The natural history of lone atrial fibrillation. N Engl J Med 317: 669
Lesser MF (1990) Safety and Efficacy of In-Office Cardioversion for Treatment of Supraventricular Arrhythmias. Am J Cardiol 66: 1267
Lown B, Amarasingham R, Neuman J (1962) New method for terminating cardiac arrhythmias: use of synchronized capacitor discharge. JAMA 182: 548
Manning WJ, Silverman DI, Gordon SPF, Krumholz HM, Douglas PS (1993) Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 328: 750–755
Mukharji J, Rehr RB, Hastillo A, Thompson JA, Hess ML, Paulsen WJ, Vetrovec GW (1990) Comparison of Atrial Contribution to Cardiac Haemodynamics in Patients with Normal and Severely Compromised Cardiac Function. Clin Cardiol 13: 639
Nachlas MM, Bix HH, Mower MM, Sieband MP (1966) Observations on defibrillation and synchronized countershock. Progr Cardiovasc Dis 9: 64
Nakazawa HK, Handa S, Nakamura Y, Oyanagi H, Hasegawa M, lshikawa N, Ozaki O, Ito K (1987) High maintenance rate of sinus rhythm after cardioversion in post-thyrotoxic chronic atrial fibrillation. Int J Cardiol 16: 47
O’Neill PG, Puleo PR, Bolli R, Rokey R (1990) Return of atrial mechanical function following electrical conversion of atrial dysrhythmias. Am Heart J 120: 353
Petersen, P., Godtfredsen, J. (1984) Atrial fibrillation - a Review of Course and Prognosis. Acta Med. Scand. 216, 5
Petersen P, Godtfredsen J Boysen G, Andersen ED, Andersen B (1989) Placebo-Controlled, Randomised Trial of Warfarin and Aspirin for Prevention of Thromboembolic Complications in Chronic Atrial Fibrillation. The Kopenhagen AFASAK Study. Lancet 1: 175
Resnekov L, Mc Donald L (1971) Electroversion of lone atrial fibrillation and flutter including haemodynamic studies at rest and on exercise. Br. Heart J., 33: 339
Resnekov L (1967) Haemodynamic studies before and after electrical conversion of atrial fibrillation and flutter to sinus rhythm. Br. Heart J 29: 700
Roy D, Marchand E, Gagné P, Chabot M, Cartier R (1986) Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J. 112: 1039
Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke Prevention in Atrial Fibrillation Study. Final Results. Circulation 84: 527
Van Gelder IC, Crijns HJ, Van Der Laarse A, Van Guist WH, Lie KI (1991) Incidence and clinical significance of ST-segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter. Am Heart J 121: 51
Van Gelder IC, Crijns HJ, Van Gilst WH, Hamer HPM, Lie KI (1991) Decrease of Right and Left Atrial Sizes After Direct- Current Electrical Cardioversion in Chronic Atrial Fibrillation. Am J Cardiol 67: 93
Van Gelder IC, Crijns HJ, Van Guist WH, Verwer R, Lie KI (1991) Prediction of Uneventful Cardioversion and Maintenance of Sinus Rhythm from Direct-Current Electrical Cardioversion of Chronic Atrial Fibrillation and Flutter. Am J Cardiol 68: 41
Walls JT, Schuder JC, Curtis JJ, Stephenson HE, McDaniel WC, Flaker G (1987) Adverse effect of permanent cardiac internal defibrillator patches on external defibrilation. PACE 10: 977
Warner ED, Dahl C, Ewy GA (1975) Myocardial Injury from Transthoracic Defibrillator Countershock. Arch Pathol 99: 55
Werner PC, Klein H (1990) Der therapeutische Nutzen von programmierter Stimulation bei Vorhofflattern. Z Kardiol 79: 366
Wolf PA, Abbott RD, Kannel WB (1987) Atrial Fibrillation: A Major Contributor to Stroke in the Elderly. Arch. Intern. Med. 147: 1561
Yamanouchi Y, Kumagai K, Tashiro N, Hiroki T, Arakawa K (1992) Transoesophageal low-energy synchronous cardioversion of atrial flutter/fibrillation in the dog. Am Heart J 123: 417
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this chapter
Cite this chapter
Fach, W.A., Heuberger, H., Becker, HJ. (1994). Elektrische Therapie von Vorhofflimmern und Vorhofflattern. In: Scheininger, M., Theisen, K. (eds) Vorhofflimmern. Steinkopff. https://doi.org/10.1007/978-3-642-93677-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-93677-7_8
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-0943-6
Online ISBN: 978-3-642-93677-7
eBook Packages: Springer Book Archive